<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00614172</url>
  </required_header>
  <id_info>
    <org_study_id>53294</org_study_id>
    <nct_id>NCT00614172</nct_id>
  </id_info>
  <brief_title>Proton Therapy for Early Stage Breast Cancer</brief_title>
  <official_title>Phase II Trial of Lumpectomy and Partial Breast Proton Therapy for Early Stage Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loma Linda University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if partial breast proton therapy is effective
      treatment for early stage breast cancer following lumpectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Radiation therapy is considered standard treatment for most women with early stage breast
      cancer following lumpectomy. Post-lumpectomy radiotherapy is a proven treatment that reduces
      cancer recurrence in the breast and improves survival. When standard whole breast radiation
      techniques are utilized, portions of the chest wall, lung and heart may also receive
      significant doses of radiation which can lead to radiation induced complications. Radiation
      techniques that limit the treatment area to the portion of the breast where the cancer arose
      can minimize and even eliminate radiation dose to the chest wall, heart and lung. This is
      called partial breast radiotherapy. This study is designed to evaluate the use of proton beam
      radiotherapy to deliver partial breast radiotherapy in women with early stage breast cancer.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2004</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the survival and recurrence rates associated with partial breast proton therapy.</measure>
    <time_frame>Every 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the toxicity and the cosmetic results with partial breast proton therapy. To determine the local tumor control and survival associated with partial breast proton therapy</measure>
    <time_frame>Every 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Early-Stage Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Proton Radiotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Two week course of proton radiotherapy to the breast.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Proton radiation therapy</intervention_name>
    <description>Proton radiotherapy will start 2-4 weeks following surgical excision. The treatment area will include the lumpectomy site with an additional margin. Daily proton therapy will be given as an out-patient over a two week coarse.</description>
    <arm_group_label>Proton Radiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Invasive ductal, medullary, papillary, colloid or tubular histologies

          -  Stages T1 or T2 (tumors &lt; or = 3 cm) from lumpectomy specimen.

          -  No more then 3 positive nodes on axillary dissection or negative sentinel node.

          -  Negative surgical margins (&gt;2mm)

        Exclusion Criteria:

          -  Invasive lobular histology

          -  Previous chemotherapy for breast cancer

          -  Extensive intraductal component

          -  Collagen vascular disease

          -  Prior malignancy unless disease-free for 5 years

          -  Patients who are pregnant or lactating
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David A. Bush, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University Department of Radiation Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jerry D. Slater, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Loma Linda University Department of Radiation Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University Medical Center / James M. Slater MD Proton Treatment Center / Department of Radiation Medicine / 11234 Anderson St.</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Bush DA, Slater JD, Garberoglio C, Yuh G, Hocko JM, Slater JM. A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy. Cancer J. 2007 Mar-Apr;13(2):114-8.</citation>
    <PMID>17476139</PMID>
  </results_reference>
  <results_reference>
    <citation>Bush DA, Slater JD, Garberoglio C, Do S, Lum S, Slater JM. Partial breast irradiation delivered with proton beam: results of a phase II trial. Clin Breast Cancer. 2011 Aug;11(4):241-5. doi: 10.1016/j.clbc.2011.03.023. Epub 2011 Jun 12.</citation>
    <PMID>21729673</PMID>
  </results_reference>
  <results_reference>
    <citation>Bush DA, Do S, Lum S, Garberoglio C, Mirshahidi H, Patyal B, Grove R, Slater JD. Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):501-5. doi: 10.1016/j.ijrobp.2014.05.1308. Epub 2014 Jul 30.</citation>
    <PMID>25084608</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2007</study_first_submitted>
  <study_first_submitted_qc>January 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2008</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loma Linda University</investigator_affiliation>
    <investigator_full_name>David Bush</investigator_full_name>
    <investigator_title>Principal Inverstigator</investigator_title>
  </responsible_party>
  <keyword>Proton</keyword>
  <keyword>Radiation</keyword>
  <keyword>Breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

